Literature DB >> 23509895

Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.

Jandee Lee1, Jae Hyun Park, Cho-Rok Lee, Woong Youn Chung, Cheong Soo Park.   

Abstract

AIMS: The objectives of this study were to compare long-term outcomes after total thyroidectomy (TT) or thyroid lobectomy (LT) in a large cohort of patients with papillary thyroid microcarcinoma (PTMC), and to determine whether tumor size (≤0.5 cm vs. >0.5 cm) has a significant impact on the extent of surgery.
METHODS: We evaluated 2014 patients with PTMC who underwent TT with central compartment node dissection (CCND; n = 1015) or LT with CCND (n = 999) between March 1986 and December 2006 and for whom complete follow-up data were available for at least 5 years (median 11.8 years, range 5-26 years). Using propensity score matching to reduce the impact of treatment selection bias and potential confounding in an observational study, we compared overall survival and disease-free survival in the overall cohort and in patients with tumors ≤0.5 cm and >0.5 cm in size.
RESULTS: After adjustment for differences in baseline clinicopathologic risk factors, we observed no significant differences between the LT and the TT groups in the risk of death (hazard ratio for the LT group 1.05, 95% confidence interval [CI] 0.71-1.47, p = 0.890) and locoregional recurrence (hazard ratio for the LT group 3.08 [CI 1.99-8.05], p = 0.194) in the overall matched cohort. Similar results were observed when we compared LT and TT in patients with tumors ≤0.5 cm and >0.5 cm.
CONCLUSIONS: The long-term rates of death and locoregional recurrence were similar in patients with PTMC who underwent LT with CCND and those who underwent TT with CCND. Therefore, completion thyroidectomy may not be recommended unless recurrence after LT is definitely detected in low-risk PTMC patients, and close follow-up is adequate in these patients. Moreover, tumor size greater than or less than 0.5 cm was not a significant determinant of the extent of surgery in patients with PTMC.

Entities:  

Mesh:

Year:  2013        PMID: 23509895     DOI: 10.1089/thy.2012.0463

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  32 in total

1.  The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.

Authors:  Ning Qu; Ling Zhang; Dao-Zhe Lin; Qing-Hai Ji; Yong-Xue Zhu; Yu Wang
Journal:  Tumour Biol       Date:  2015-12-21

2.  Lobectomy and prophylactic central neck dissection for papillary thyroid microcarcinoma: do involved lymph nodes mandate completion thyroidectomy?

Authors:  Cho Rok Lee; Haiyoung Son; Sohee Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

3.  Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.

Authors:  Ji Soo Choi; Eun-Kyung Kim; Hee Jung Moon; Jin Young Kwak
Journal:  Endocrine       Date:  2014-05-25       Impact factor: 3.633

4.  Current management of papillary thyroid microcarcinoma in Canada.

Authors:  Mazin Merdad; Antoine Eskander; John De Almeida; Jeremy Freeman; Lorne Rotstein; Shereen Ezzat; Anna M Sawka; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-08-14

5.  Recurrence-free survival after total thyroidectomy and lobectomy in patients with papillary thyroid microcarcinoma.

Authors:  M van Gerwen; M Alsen; E Lee; C Sinclair; E Genden; E Taioli
Journal:  J Endocrinol Invest       Date:  2020-07-10       Impact factor: 4.256

6.  Extent of Thyroidectomy in Differentiated Thyroid Cancers-Review of Evidence.

Authors:  Samskruthi P Murthy; Deepak Balasubramanian; Adharsh Anand; Shashikant Vishnubhai Limbachiya; Narayana Subramaniam; Vasantha Nair; Krishnakumar Thankappan; Subramania Iyer
Journal:  Indian J Surg Oncol       Date:  2017-05-09

Review 7.  Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.

Authors:  Ning Qu; Ling Zhang; Qing-Hai Ji; Jia-Ying Chen; Yong-Xue Zhu; Yi-Ming Cao; Qiang Shen
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

8.  New Recommendations for Extent of Thyroidectomy and Active Surveillance for the Treatment of Differentiated Thyroid Cancer.

Authors:  Ralph P Tufano; Maisie Shindo; Ashok R Shaha
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-07-01       Impact factor: 6.223

Review 9.  The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.

Authors:  Guangfu Hu; Wei Zhu; Weige Yang; Hong Wang; Lei Shen; Hongwei Zhang
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

10.  Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.

Authors:  Yi Gao; Ning Qu; Ling Zhang; Jia-Ying Chen; Qing-Hai Ji
Journal:  Tumour Biol       Date:  2015-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.